Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia

NCT03891862 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Tardive Dyskinesia (TD)

Interventions

DRUG: Valbenazine
DRUG: Placebo oral capsule

Sponsor

Neurocrine Biosciences